Skip to main content
Clinical Trials/JPRN-jRCTs042210158
JPRN-jRCTs042210158
Recruiting
N/A

Application of diagnosis and treatment monitoring of breast cancer by time-resolved spectroscopy system (TRS-21-6W)

Koizumi Kei0 sites60 target enrollmentMarch 7, 2022
Conditionsbreast cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
breast cancer
Sponsor
Koizumi Kei
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 7, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Other
Sex
Female

Investigators

Sponsor
Koizumi Kei

Eligibility Criteria

Inclusion Criteria

  • 1\.Female patients age 20 or older
  • 2\.Patients with an initial diagnosis of primary breast cancer (including bilateral breast cancer)
  • 3 Patients scheduled neoadjuvant chemotherapy or endocrine therapy
  • 4\.Patients whose consent for this study has been obtained by signing the consent form.

Exclusion Criteria

  • 1\.Patients with photosensitivity
  • 2\.Patients who cannot keep the same posture for the measurement time (about 40 minutes)
  • 3\.Patients with obvious distant metastasis (lung metastasis, liver metastasis, bone metastasis, etc.)
  • 4\.Patients with recurrent breast cancer
  • 5\.Patients who are judged by the principal investigator (or sub\-investigator) to be in a condition inappropriate for the participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials